OET Features in Top UK Life Science Companies article.
February 2, 2021
OET is delighted to be featured in a recent articl...
Read More
Follow Us!
Over the last decade OET has developed to become a leading centre of excellence in the application and development of baculovirus science. Keep up to date with all our news, research and insights on the website or visit our exclusive OET blog – Bac to the Future.
THE HOME OF FLASHBAC™ TECHNOLOGY
Oxford Expression Technologies’ flashBAC™ baculovirus expression kits allow you to express superior recombinant protein yields in a shorter time when compared to other expression systems. The flashBAC™ technology is also highly flexible thanks to its compatibility with a wide variety of transfer vectors. Have you tried it yet?
Oxford Expression Technologies
Oxford Expression Technologies is a biotechnology company in the recombinant protein expression field, and a recognised centre of excellence for baculovirus expression. OET provides protein expression products, services and consultancy.
OET Products
OET specialises in recombinant protein expression. Our flashBAC™ range of baculovirus expression vectors have been designed for ease of use, improved recombinant protein expression levels and adaptability to high throughput systems. Supported by an optimised range of transfer vectors, transfection reagents and cell culture media to ensure a powerful and versatile system.
Read MoreOET Services
OET provides a high quality, tailor made comprehensive recombinant protein expression service, from gene synthesis to baculovirus production through to protein expression and purification. With over 25 years of experience working with the baculovirus system with clients in academia and in industry we work closely with our customers to meet their targets.
Read MoreLATEST NEWS
OET awarded Innovate UK grant for Covid-19 vaccine development
September 3, 2020
Government funding announced for Oxford biotech co...
Read More
SARS-CoV-2 (COVID-19 Virus) Research
May 7, 2020
OET is currently helping COVID-19 research efforts...
Read More